Clinical Trial: Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953024) titled 'Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test' on April 17.

Brief Summary: This study aims to validate the percent agreement of the INSTI Multiplex Human Immunodeficiency (HIV) 1/2 syphilis antibody (Ab) test (INSTI POCT) when used as a self-test by patients compared to conventional serologic testing.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Hiv Syphilis

Intervention: DIAGNOSTIC_TEST: INSTI HIV/syphilis Point of Care Self-Test Administration

The INSTI Human Immunodeficiency Virus (HIV)/syphilis POCT is a rapid, single-use, flow-through immunoassay that is Health Can...